Impact of Coronary Artery Severity and Revascularization Prior to Transcatheter Aortic Valve Implantation

Published: March 15, 2020
Category: Bibliography
Authors: Dennis T. Ko, Feng Qiu, Gabby G. Elbaz, Harindra C. Wijeysundera, Ikki Komatsu, Kayley A. Henning, Peter C. Austin, Sam Radhakrishnan, Stephen E. Fremes
Countries: Canada
Language: English
Types: Care Management, chronic condition, Outcomes, Performance Analysis, Population Health
Settings: Government, Hospital



The prevalence of coexisting coronary artery disease (CAD) is high in patients who underwent transcatheter aortic valve implantation (TAVI). Our objective was to first determine if the severity of CAD before TAVI had an important impact on post-TAVI outcomes and second, if revascularization with percutaneous coronary intervention (PCI) before TAVI modified this relation.


In this retrospective population-based study in Ontario, Canada, we identified all patients with obstructive CAD who underwent TAVI from April 1, 2012 to March 31, 2017.


Our primary outcomes of interest were all-cause mortality within 30-day and 1-year post-TAVI procedure. Secondary outcomes included 30-day and 1-year all-cause readmissions. We developed multivariable Cox proportional hazard models, with a robust sandwich-type variance estimator to account for clustering within TAVI centers. These models included an interaction term between severity of CAD and PCI before TAVI. The study cohort included 888 of whom 444 (50%) patients underwent PCI before TAVI procedure. In the Cox models, we found that severity of CAD before TAVI was not significantly associated with post-TAVI outcomes. The only exception was 1 to 2 vessel/s disease which was a significant predictor of 1-year readmission. Pre-TAVI PCI was not significantly associated with outcomes, nor did it modify the relation between severity of CAD pre-TAVI and outcomes.


In conclusion, we did not find a consistent relation between severity of CAD and revascularization with post-TAVI outcomes.

coexisting coronary artery disease,transcatheter aortic valve implantation,percutaneous coronary intervention,outcomes

Please log in/register to access.

Log in/Register

LinkedIn Facebook Twitter

© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System.
All rights reserved. Terms of Use Privacy Statement

Back to top